TY - JOUR
T1 - The prevalence and correlates of the positive androgen deficiency in the aging male (ADAM) questionnaire among psychiatric outpatients
T2 - A cross-sectional survey of 176 men in a general hospital in Taiwan
AU - Lee, Chin Pang
AU - Chen, Yu
AU - Jiang, Kun Hao
AU - Chu, Chun Lin
AU - Hsu, Shih Chieh
AU - Chen, Jiun Liang
AU - Chen, Ching Yen
N1 - Publisher Copyright:
© 2015 Lee et al.
PY - 2015/1/20
Y1 - 2015/1/20
N2 - Introduction: The Androgen Deficiency in the Aging Male (ADAM) questionnaire is widely used to screen for late-onset hypogonadism. The positive response to the ADAM questionnaire (positive ADAM) has been associated with depression and poorer quality of life in a number of studies. It is unclear whether there is any value of the ADAM questionnaire in psychiatric populations. In this study, we aimed to determine the utility of the ADAM questionnaire in a convenient sample of male psychiatric outpatients.Methods: One hundred and seventy-six men (mean age: 54.3 years; standard deviation: 10.7 years; range: 40–80 years) completed the ADAM questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Aging Males’ Symptoms (AMS) scale. Anxiety was defined as a HADS anxiety subscore $8; depression as a HADS depression subscore $8; and moderate/severe impairment of health-related quality of life (HQoL) as AMS $37. ADAM, anxiety, and depression was used to model the moderate/severe impairment of HQoL.Conclusion: The ADAM questionnaire can be used to screen the sexual symptoms but not depression/anxiety in male psychiatric outpatients. Positive ADAM may indicate moderate/severe impairment of HQoL.Results: One hundred and sixty-four (93%) men had positive ADAM. Positive ADAM was associated with a lower body mass index (P,0.05) and moderate/severe impairment of HQoL (P,0.001), but was not associated with anxiety or depression (P.0.05). Positive ADAM was associated with five symptoms of the AMS scale: “decline of one’s feeling of general well-being”, “depressive mood”, and three sexual symptoms. In regression analysis, positive ADAM was associated with increased risk of moderate/severe impairment of HQoL (unadjusted odds ratio 20.1, 95% confidence interval 3.77–372, P,0.01), which remained significant with covariates of anxiety and depression (adjusted odds ratio 15.6, 95% confidence interval 2.52–309, P,0.05).
AB - Introduction: The Androgen Deficiency in the Aging Male (ADAM) questionnaire is widely used to screen for late-onset hypogonadism. The positive response to the ADAM questionnaire (positive ADAM) has been associated with depression and poorer quality of life in a number of studies. It is unclear whether there is any value of the ADAM questionnaire in psychiatric populations. In this study, we aimed to determine the utility of the ADAM questionnaire in a convenient sample of male psychiatric outpatients.Methods: One hundred and seventy-six men (mean age: 54.3 years; standard deviation: 10.7 years; range: 40–80 years) completed the ADAM questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Aging Males’ Symptoms (AMS) scale. Anxiety was defined as a HADS anxiety subscore $8; depression as a HADS depression subscore $8; and moderate/severe impairment of health-related quality of life (HQoL) as AMS $37. ADAM, anxiety, and depression was used to model the moderate/severe impairment of HQoL.Conclusion: The ADAM questionnaire can be used to screen the sexual symptoms but not depression/anxiety in male psychiatric outpatients. Positive ADAM may indicate moderate/severe impairment of HQoL.Results: One hundred and sixty-four (93%) men had positive ADAM. Positive ADAM was associated with a lower body mass index (P,0.05) and moderate/severe impairment of HQoL (P,0.001), but was not associated with anxiety or depression (P.0.05). Positive ADAM was associated with five symptoms of the AMS scale: “decline of one’s feeling of general well-being”, “depressive mood”, and three sexual symptoms. In regression analysis, positive ADAM was associated with increased risk of moderate/severe impairment of HQoL (unadjusted odds ratio 20.1, 95% confidence interval 3.77–372, P,0.01), which remained significant with covariates of anxiety and depression (adjusted odds ratio 15.6, 95% confidence interval 2.52–309, P,0.05).
KW - Aging Males’ Symptoms scale
KW - Anxiety
KW - Depression
KW - Health-related quality of life
UR - http://www.scopus.com/inward/record.url?scp=84930474410&partnerID=8YFLogxK
U2 - 10.2147/NDT.S75701
DO - 10.2147/NDT.S75701
M3 - 文章
AN - SCOPUS:84930474410
SN - 1178-2021
VL - 11
SP - 185
EP - 189
JO - Neuropsychiatric Disease and Treatment
JF - Neuropsychiatric Disease and Treatment
ER -